Blake Mycoskie, the founder of TOMS Shoes, has pledged to commit $100 million to support psychedelic research.Mycoskie believes in the potential of psychedelic therapy to address mental health issues and wants to contribute to advancing scientific understanding in this field. The donation will go towards various initiatives, including clinical trials, research institutions, and advocacy efforts focused on psychedelic-assisted therapies.Mycoskie hopes that his contribution will help destigmatize psychedelics and pave the way for their integration into mainstream mental healthcare. This significant investment from a prominent entrepreneur reflects the growing interest and support for psychedelic research and its potential to revolutionize mental health treatments.
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.